Abacavir and lamivudine

Zydus Pharmaceuticals USA Inc.🇺🇸 United States

FDA Page

Effective Date: May 15, 2023
Approval ID: 85071242-ccf6-43d7-8ee6-87273d21256f
Products: 1 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ABACAVIR and LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR and LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004

Quick Stats

Total Products1

Labelers2

Label Sections28

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.